| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 6-K |
| 13 Nov 2026 | SCHEDULE 13G |
| 12 Nov 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 04 Nov 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 30 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 27 Oct 2026 |
Form 4: Voliotis Dimitris, Chief Medical Officer
Granted 30,887,000 Option (Right to buy) |
| 27 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 26 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 20 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 14 Oct 2026 | SCHEDULE 13G |
| 05 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 01 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 30 Sep 2026 | ANNUAL REPORT |
| 30 Sep 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 23 Sep 2026 | EFFECT |
| 23 Sep 2026 | PROSPECTUS |
| 22 Sep 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 14 Sep 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 14 Sep 2026 | REGISTRATION STATEMENT |
| 11 Sep 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
Loading...